Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.
Phase II study of "dose-dense" high-dose chemotherapy treatment with peripheral-blood progenitor-cell support as primary treatment for patients with advanced ovarian cancer.
复制标题
以外周血祖细胞支持为主要治疗的“剂量密集”高剂量化疗治疗晚期卵巢癌患者的 II 期研究。
DOI：
10.1200/jco.1998.16.5.1852
复制
发表时间：
1998
期刊：
影响因子：
--
通讯作者：
Spriggs,DR
中科院分区：
文献类型：
--
作者：
Aghajanian,C;Fennelly,D;Shapiro,F;Waltzman,R;Almadrones,L;O'Flaherty,C;O'Conner,K;Venkatraman,E;Barakat,R;Curtin,J;Brown,C;Reich,L;Wuest,D;Norton,L;Hoskins,W;Spriggs,DR
